Sofina Ventures exits 1.28% of Honasa Consumer in ₹177 Cr bulk deal at ₹424/share
Belgian investor Sofina Ventures offloaded 41.78 Lakh shares of Mamaearth parent Honasa Consumer via a ₹177.2 Cr bulk deal, even as the stock is up 42% YTD. The exit comes amid Honasa's 'Honasa 3.0' reset and its ₹135 Cr Fluence Pharma buy targeting ₹5,500 Cr revenue and 15%+ EBITDA by FY31.
Sofina Ventures sold a 1.28% stake in Honasa Consumer (Mamaearth parent) via a ₹177 Cr bulk deal at ₹424/share, amid Honasa's 'Honasa 3.0' strategy and recent Fluence Pharma acquisition entering nutraceuticals.